{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:37:01Z","timestamp":1786721821969,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hereditas"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Rheumatoid arthritis (RA) is a chronic inflammatory disease. This study aims to identify candidate therapeutic targets and promising drugs for RA.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>RA-related microarray datasets (GSE77298 and GSE206848) and inflammatory genes (IRGs) were downloaded from Gene Expression Omnibus database and GeneCards database, respectively. After removing batch effects, differentially expressed genes (DEGs) were screened using filtering criteria of <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05 and |log2(fold change)|&gt;\u20091. Differentially expressed IRGs (DE-IRGs) were then obtained. Key gene modules were identified by weighted gene co-expression network analysis (WGCNA), and the hub genes were then identified from the results of protein\u2013protein interaction (PPI) network analysis, WGCNA and DE-IRGs, and validated by a external dataset GSE93272. Receiver operating characteristic (ROC) curve was used to evaluate the diagnostic effect of the predicted hub genes. In addition, drug prediction was performed through virtual screening. mRNA and protein expression of cluster of differentiation 36 (CD36) were detected by RT-qPCR and Western blot. After RA fibroblast-like synovial cells (RA-FLS) were treated with piceatannol and epicatechin, cell proliferation was detected by CCK-8 assay, and flow cytometry was used to detect cell cycle and apoptosis, and the secretion of inflammatory cytokines was detected by enzyme-linked immunosorbent assay.\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Three hub genes were finally identified, including CD36, perilipin 1 and lipoprotein lipase. CD36 was further identified as a candidate biomarker and therapeutic target for RA, which had relatively good diagnostic efficacy for RA. Compared with fibroblast-like synovial cells (FLS), mRNA and protein expression levels of CD36 in RA-FLS were significantly up-regulated (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05). Piceatannol and epicatechin had good binding affinity with CD36 (docking score\u2009&lt;\u2009-5 kcal\/mol), and piceatannol treatment or epicatechin treatment inhibited the proliferation and inflammation of RA-FLS and induced cell cycle arrest and apoptosis (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05).\n<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>CD36 is a potential biomarker and therapeutic target associated with synovial inflammation of RA, and piceatannol and epicatechin are potential natural drugs for RA treatment. Overall, these findings provide new insights into the clinical diagnosis and treatment of RA.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41065-025-00450-3","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T06:17:20Z","timestamp":1748931440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of CD36 as a contributor in inflammatory response of rheumatoid arthritis and screening of feasible bioactive drugs targeting it"],"prefix":"10.1186","volume":"162","author":[{"given":"Dan","family":"Xuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"issue":"1","key":"450_CR1","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1186\/s13075-021-02681-x","volume":"23","author":"M Wang","year":"2021","unstructured":"Wang M, Chen J, Lin X, Huang L, Li H, Wen C, He Z. High humidity aggravates the severity of arthritis in collagen-induced arthritis mice by upregulating xylitol and L-pyroglutamic acid. Arthritis Res Ther. 2021Dec 1;23(1):292.","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"450_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24897","volume":"37","author":"S Afrasiabi","year":"2023","unstructured":"Afrasiabi S, Chiniforush N, Partoazar A, Goudarzi R. The role of bacterial infections in rheumatoid arthritis development and novel therapeutic interventions: Focus on oral infections. J Clin Lab Anal. 2023Apr;37(8): e24897.","journal-title":"J Clin Lab Anal"},{"issue":"4","key":"450_CR3","doi-asserted-by":"publisher","first-page":"880","DOI":"10.3390\/cells9040880","volume":"9","author":"YJ Lin","year":"2020","unstructured":"Lin YJ, Anzaghe M, Sch\u00fclke S. Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis. Cells. 2020Apr 3;9(4):880.","journal-title":"Cells"},{"issue":"5","key":"450_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00296-020-04731-0","volume":"41","author":"K Almutairi","year":"2021","unstructured":"Almutairi K, Nossent J, Preen D, Keen H, Inderjeeth C. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review. Rheumatol Int. 2021May;41(5):863\u201377.","journal-title":"Rheumatol Int"},{"issue":"1","key":"450_CR5","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13075-017-1398-6","volume":"19","author":"F Teng","year":"2017","unstructured":"Teng F, Felix KM, Bradley CP, Naskar D, Ma H, Raslan WA, Wu HJ. The impact of age and gut microbiota on Th17 and Tfh cells in K\/BxN autoimmune arthritis. Arthritis Res Ther. 2017Aug 15;19(1):188.","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"450_CR6","doi-asserted-by":"publisher","first-page":"1051082","DOI":"10.3389\/fimmu.2022.1051082","volume":"22","author":"D Wu","year":"2022","unstructured":"Wu D, Luo Y, Li T, Zhao X, Lv T, Fang G, Ou P, Li H, Luo X, Huang A, Pang Y. Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment. Front Immunol. 2022Dec;22(13):1051082.","journal-title":"Front Immunol"},{"issue":"11","key":"450_CR7","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.3390\/cells10112857","volume":"10","author":"AF Radu","year":"2021","unstructured":"Radu AF, Bungau SG. Management of Rheumatoid Arthritis: An Overview. Cells. 2021Oct 23;10(11):2857.","journal-title":"Cells"},{"issue":"6","key":"450_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","volume":"27","author":"Q Guo","year":"2018","unstructured":"Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018Apr;27(6):15.","journal-title":"Bone Res"},{"issue":"2022","key":"450_CR9","first-page":"1208970","volume":"12","author":"K Wi\u0119cek","year":"2022","unstructured":"Wi\u0119cek K, Kupczyk P, Chodaczek G, Wo\u017aniak M. The Impact of Curcumin on the Inflammatory Profile of SW982 Cells in a Rheumatoid Arthritis Model. J Immunol Res. 2022Apr;12(2022):1208970.","journal-title":"J Immunol Res"},{"issue":"11","key":"450_CR10","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1136\/ard-2022-222605","volume":"81","author":"Y Qin","year":"2022","unstructured":"Qin Y, Cai ML, Jin HZ, Huang W, Zhu C, Bozec A, Huang J, Chen Z. Age-associated B cells contribute to the pathogenesis of rheumatoid arthritis by inducing activation of fibroblast-like synoviocytes via TNF-\u03b1-mediated ERK1\/2 and JAK-STAT1 pathways. Ann Rheum Dis. 2022Nov;81(11):1504\u201314.","journal-title":"Ann Rheum Dis"},{"key":"450_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102304","volume":"67","author":"V Tsaltskan","year":"2022","unstructured":"Tsaltskan V, Firestein GS. Targeting fibroblast-like synoviocytes in rheumatoid arthritis. Curr Opin Pharmacol. 2022Dec;67: 102304.","journal-title":"Curr Opin Pharmacol"},{"issue":"1","key":"450_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40709-020-00131-4","volume":"28","author":"L Wang","year":"2021","unstructured":"Wang L, Zhao Q, Wang N, Ding Y, Kong L, Wang J. Circ_0000396 inhibits rheumatoid arthritis synovial fibroblast growth and inflammatory response via miR-203\/HBP1 axis. J Biol Res (Thessalon). 2021Jan 6;28(1):1.","journal-title":"J Biol Res (Thessalon)"},{"issue":"5","key":"450_CR13","first-page":"2393","volume":"42","author":"X Wang","year":"2018","unstructured":"Wang X, Wang X, Sun J, Fu S. An enhanced RRM2 siRNA delivery to rheumatoid arthritis fibroblast-like synoviocytes through a liposome-protamine-DNA-siRNA complex with cell permeable peptides. Int J Mol Med. 2018Nov;42(5):2393\u2013402.","journal-title":"Int J Mol Med"},{"issue":"13","key":"450_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/1471-2105-13-335","volume":"24","author":"J Taminau","year":"2012","unstructured":"Taminau J, Meganck S, Lazar C, Steenhoff D, Coletta A, Molter C, Duque R, de Schaetzen V, Weiss Sol\u00eds DY, Bersini H, Now\u00e9 A. Unlocking the potential of publicly available microarray data using inSilicoDb and inSilicoMerging R\/Bioconductor packages. BMC Bioinformatics. 2012Dec;24(13):335.","journal-title":"BMC Bioinformatics"},{"issue":"13","key":"450_CR15","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2018.13103","volume":"320","author":"D Aletaha","year":"2018","unstructured":"Aletaha D, Smolen JS. Diagnosis and Management of Rheumatoid Arthritis: A Review. JAMA. 2018Oct 2;320(13):1360\u201372.","journal-title":"JAMA"},{"issue":"10271","key":"450_CR16","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0140-6736(20)32341-2","volume":"397","author":"F Humby","year":"2021","unstructured":"Humby F, Durez P, Buch MH, Lewis MJ, Rizvi H, Rivellese F, Nerviani A, Giorli G, Mahto A, Montecucco C, Lauwerys B, Ng N, Ho P, Bombardieri M, Rom\u00e3o VC, Verschueren P, Kelly S, Sainaghi PP, Gendi N, Dasgupta B, Cauli A, Reynolds P, Ca\u00f1ete JD, Moots R, Taylor PC, Edwards CJ, Isaacs J, Sasieni P, Choy E, Pitzalis C. R4RA collaborative group. Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial. Lancet. 2021;397(10271):305\u201317.","journal-title":"Lancet"},{"key":"450_CR17","doi-asserted-by":"publisher","first-page":"l67","DOI":"10.1136\/bmj.l67","volume":"364","author":"JE Gottenberg","year":"2019","unstructured":"Gottenberg JE, Morel J, Perrodeau E, Bardin T, Combe B, Dougados M, Flipo RM, Saraux A, Schaeverbeke T, Sibilia J, Soubrier M, Vittecoq O, Baron G, Constantin A, Ravaud P, Mariette X. French Society of Rheumatology and the investigators participating in AIR, ORA, and REGATE registries. Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study. BMJ. 2019;364:l67.","journal-title":"BMJ."},{"issue":"136","key":"450_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112264","volume":"30","author":"J He","year":"2024","unstructured":"He J, Lin X, Gao X, Luan H, Guo Y, Wang X, Tao C, Wang Q, Chen J. Novel artesunate and isatin hybrid CT3-1 suppresses collagen-induced arthritis through abrogating dendritic cell chemotaxis-induced by CCR5. Int Immunopharmacol. 2024Jul;30(136): 112264.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"450_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10067-017-3800-9","volume":"37","author":"M Lv","year":"2018","unstructured":"Lv M, Miao J, Zhao P, Luo X, Han Q, Wu Z, Zhang K, Zhu P. CD147-mediated chemotaxis of CD4+CD161+ T cells may contribute to local inflammation in rheumatoid arthritis. Clin Rheumatol. 2018Jan;37(1):59\u201366.","journal-title":"Clin Rheumatol"},{"issue":"10","key":"450_CR20","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1177\/1535370213503262","volume":"238","author":"I Voloshyna","year":"2013","unstructured":"Voloshyna I, Modayil S, Littlefield MJ, Belilos E, Belostocki K, Bonetti L, Rosenblum G, Carsons SE, Reiss AB. Plasma from rheumatoid arthritis patients promotes pro-atherogenic cholesterol transport gene expression in THP-1 human macrophages. Exp Biol Med (Maywood). 2013Oct;238(10):1192\u20137.","journal-title":"Exp Biol Med (Maywood)"},{"issue":"17","key":"450_CR21","doi-asserted-by":"publisher","first-page":"4893","DOI":"10.7150\/thno.36037","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang J, Li Y. CD36 tango in cancer: signaling pathways and functions. Theranostics. 2019Jul 9;9(17):4893\u2013908.","journal-title":"Theranostics"},{"issue":"1","key":"450_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/cvr\/cvaa319","volume":"118","author":"H Shu","year":"2022","unstructured":"Shu H, Peng Y, Hang W, Nie J, Zhou N, Wang DW. The role of CD36 in cardiovascular disease. Cardiovasc Res. 2022Jan 7;118(1):115\u201329.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"450_CR23","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1080\/15548627.2023.2196876","volume":"19","author":"Y Li","year":"2023","unstructured":"Li Y, Xu J, Chen W, Wang X, Zhao Z, Li Y, Zhang L, Jiao J, Yang Q, Ding Q, Yang P, Wei L, Chen Y, Chen Y, Ruan XZ, Zhao L. Hepatocyte CD36 modulates UBQLN1-mediated proteasomal degradation of autophagic SNARE proteins contributing to septic liver injury. Autophagy. 2023Sep;19(9):2504\u201319.","journal-title":"Autophagy"},{"issue":"1","key":"450_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1536\/ihj.18-114","volume":"60","author":"K Nakatani","year":"2019","unstructured":"Nakatani K, Masuda D, Kobayashi T, Sairyo M, Zhu Y, Okada T, Naito AT, Ohama T, Koseki M, Oka T, Akazawa H, Nishida M, Komuro I, Sakata Y, Yamashita S. Pressure Overload Impairs Cardiac Function in Long-Chain Fatty Acid Transporter CD36-Knockout Mice. Int Heart J. 2019Jan 25;60(1):159\u201367.","journal-title":"Int Heart J"},{"issue":"3","key":"450_CR25","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.jhep.2018.04.006","volume":"69","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang C, Luo X, Wang P, Zhou W, Zhong S, Xie Y, Jiang Y, Yang P, Tang R, Pan Q, Hall AR, Luong TV, Fan J, Varghese Z, Moorhead JF, Pinzani M, Chen Y, Ruan XZ. CD36 palmitoylation disrupts free fatty acid metabolism and promotes tissue inflammation in non-alcoholic steatohepatitis. J Hepatol. 2018Sep;69(3):705\u201317.","journal-title":"J Hepatol"},{"issue":"2","key":"450_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/ni.1836","volume":"11","author":"CR Stewart","year":"2010","unstructured":"Stewart CR, Stuart LM, Wilkinson K, van Gils JM, Deng J, Halle A, Rayner KJ, Boyer L, Zhong R, Frazier WA, Lacy-Hulbert A, El Khoury J, Golenbock DT, Moore KJ. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2010Feb;11(2):155\u201361.","journal-title":"Nat Immunol"},{"issue":"1","key":"450_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1186\/s13075-020-02369-8","volume":"22","author":"C Choi","year":"2020","unstructured":"Choi C, Jeong W, Ghang B, Park Y, Hyun C, Cho M, Kim J. Cyr61 synthesis is induced by interleukin-6 and promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther. 2020Nov 23;22(1):275.","journal-title":"Arthritis Res Ther"},{"key":"450_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.151958","volume":"53","author":"S Yuan","year":"2022","unstructured":"Yuan S, Li X, Lin A, Larsson SC. Interleukins and rheumatoid arthritis: bi-directional Mendelian randomization investigation. Semin Arthritis Rheum. 2022Apr;53: 151958.","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"450_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.taap.2015.06.017","volume":"287","author":"S Umar","year":"2015","unstructured":"Umar S, Hedaya O, Singh AK, Ahmed S. Thymoquinone inhibits TNF-\u03b1-induced inflammation and cell adhesion in rheumatoid arthritis synovial fibroblasts by ASK1 regulation. Toxicol Appl Pharmacol. 2015Sep 15;287(3):299\u2013305.=","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"450_CR30","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/s41584-020-0413-5","volume":"16","author":"G Nygaard","year":"2020","unstructured":"Nygaard G, Firestein GS. Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes. Nat Rev Rheumatol. 2020Jun;16(6):316\u201333.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"450_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.761841","volume":"13","author":"H Hu","year":"2021","unstructured":"Hu H, Zhang F, Li L, Liu J, Ao Q, Li P, Zeng J, Li L. Identification and Validation of ATF3 Serving as a Potential Biomarker and Correlating With Pharmacotherapy Response and Immune Infiltration Characteristics in Rheumatoid Arthritis. Front Mol Biosci. 2021Dec;13(8): 761841.","journal-title":"Front Mol Biosci"},{"issue":"1","key":"450_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3390\/md20010029","volume":"20","author":"L Luo","year":"2021","unstructured":"Luo L, Zhong A, Wang Q, Zheng T. Structure-Based Pharmacophore Modeling, Virtual Screening, Molecular Docking, ADMET, and Molecular Dynamics (MD) Simulation of Potential Inhibitors of PD-L1 from the Library of Marine Natural Products. Mar Drugs. 2021Dec 25;20(1):29.","journal-title":"Mar Drugs"},{"issue":"5","key":"450_CR33","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3892\/mmr.2022.12696","volume":"25","author":"X Gao","year":"2022","unstructured":"Gao X, Kang X, Lu H, Xue E, Chen R, Pan J, Ma J. Piceatannol suppresses inflammation and promotes apoptosis in rheumatoid arthritis-fibroblast-like synoviocytes by inhibiting the NF-\u03baB and MAPK signaling pathways. Mol Med Rep. 2022May;25(5):180.","journal-title":"Mol Med Rep"},{"issue":"2022","key":"450_CR34","doi-asserted-by":"publisher","first-page":"2657713","DOI":"10.1155\/2022\/2657713","volume":"24","author":"J Ling","year":"2022","unstructured":"Ling J, Wu Y, Zou X, Chang Y, Li G, Fang M. (-)-Epicatechin Reduces Neuroinflammation, Protects Mitochondria Function, and Prevents Cognitive Impairment in Sepsis-Associated Encephalopathy. Oxid Med Cell Longev. 2022May;24(2022):2657713.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"450_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.5114\/aoms\/119022","volume":"20","author":"S Li","year":"2021","unstructured":"Li S, Du J, Gan H, Chen J, Zhou Y, Tian J, Ling G, Li F. Resveratrol promotes apoptosis and G2\/M cell cycle arrest of fibroblast-like synoviocytes in rheumatoid arthritis through regulation of autophagy and the serine-threonine kinase-p53 axis. Arch Med Sci. 2021Feb 18;20(1):280\u20138.","journal-title":"Arch Med Sci"},{"issue":"12","key":"450_CR36","first-page":"2022","volume":"12","author":"SJ Jin","year":"2022","unstructured":"Jin SJ, Song Y, Park HS, Park KW, Lee S, Kang H. Harmine Inhibits Multiple TLR-Induced Inflammatory Expression through Modulation of NF-\u03baB p65, JNK, and STAT1. Life (Basel). 2022Dec 3;12(12):2022.","journal-title":"Life (Basel)"},{"issue":"19","key":"450_CR37","doi-asserted-by":"publisher","first-page":"6474","DOI":"10.3390\/molecules27196474","volume":"27","author":"A Karami","year":"2022","unstructured":"Karami A, Fakhri S, Kooshki L, Khan H. Polydatin: Pharmacological Mechanisms, Therapeutic Targets, Biological Activities, and Health Benefits. Molecules. 2022Oct 1;27(19):6474.","journal-title":"Molecules"},{"issue":"3","key":"450_CR38","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3390\/nu11030699","volume":"11","author":"K Masodsai","year":"2019","unstructured":"Masodsai K, Lin YY, Chaunchaiyakul R, Su CT, Lee SD, Yang AL. Twelve-Week Protocatechuic Acid Administration Improves Insulin-Induced and Insulin-Like Growth Factor-1-Induced Vasorelaxation and Antioxidant Activities in Aging Spontaneously Hypertensive Rats. Nutrients. 2019Mar 25;11(3):699.","journal-title":"Nutrients"},{"key":"450_CR39","doi-asserted-by":"publisher","first-page":"9831263","DOI":"10.1155\/2016\/9831263","volume":"2016","author":"SP Wang","year":"2016","unstructured":"Wang SP, Lin SC, Li S, Chao YH, Hwang GY, Lin CC. Potent Antiarthritic Properties of Phloretin in Murine Collagen-Induced Arthritis. Evid Based Complement Alternat Med. 2016;2016:9831263.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"3","key":"450_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3390\/molecules27030585","volume":"27","author":"NM Yunos","year":"2022","unstructured":"Yunos NM, Amin NDM, Jauri MH, Ling SK, Hassan NH, Sallehudin NJ. The In Vitro Anti-Cancer Activities and Mechanisms of Action of 9-Methoxycanthin-6-one from Eurycoma longifolia in Selected Cancer Cell Lines. Molecules. 2022Jan 18;27(3):585.","journal-title":"Molecules"},{"issue":"8","key":"450_CR41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0136122","volume":"10","author":"H Lee","year":"2015","unstructured":"Lee H, Kang SW, Byun HS, Jeon J, Park KA, Kang K, Seo W, Won M, Seok JH, Han MD, Shen HM, Hur GM. Brazilin Limits Inflammatory Responses through Induction of Prosurvival Autophagy in Rheumatoid Fibroblast-Like Synoviocytes. PLoS ONE. 2015Aug 21;10(8): e0136122.","journal-title":"PLoS ONE"}],"container-title":["Hereditas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41065-025-00450-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41065-025-00450-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T07:03:28Z","timestamp":1748934208000},"score":1,"resource":{"primary":{"URL":"https:\/\/hereditasjournal.biomedcentral.com\/articles\/10.1186\/s41065-025-00450-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["450"],"URL":"https:\/\/doi.org\/10.1186\/s41065-025-00450-3","relation":{},"ISSN":["1601-5223"],"issn-type":[{"value":"1601-5223","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"18 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}